Global Clinical Microbiology Market is Estimated to Value Over USD 5.9 Billion by 2026 End

  • 26 Sep 2019

Global Clinical Microbiology Market is estimated to value over USD 5.9 billion by 2026 end and register a CAGR of over 6.2% during the forecast period 2019 to 2026

 

The advancements in technology in the diagnosis of disease, increasing prevalence of infectious diseases and growing epidemic outbreak and increased funding for public and private investments in disease diagnosis are the crucial factors steering the global clinical microbiology market growth.

 

The market is bifurcated based on products as reagents and instruments. The instruments segment is anticipated to hold the largest global clinical microbiology market share over the forecast period. Factors such as the substantial adoption of traditional laboratory instruments amongst end users, advancements in technology in proteomics like the integration of PCR, nanotechnology and micro fluids with qPCR methods and the current trend of the automation of laboratories are boosting the segment growth.

 

The instruments segment is fragmented into microbiology analyzers and laboratory instruments. The microbiology analyzers product is predicted to proliferate with a high CAGR over the forecast period. This growth can be credited to the rising adoption of advanced-level analyzers for diagnosis of disease by end users and advancements in technology in molecular diagnostics instruments.

 

Furthermore, the reagents product segment is further categorized into general reagents and pathogen-specific kits. The pathogen-specific kits are predicted to augment substantially in the next five years. The segment growth can be credited to factors like the flexibility of pathogen kits to end-users to optimize reactions for better outcomes and increasing preference of patients across multiple nations for accurate and early diagnosis of diseases.

 

The market is segmented based on indication as bloodstream infections, sexually transmitted diseases, respiratory diseases, urinary tract infections, periodontal diseases, gastrointestinal diseases and other diseases like connective tissue and joint diseases, central nervous system infections, skin diseases and cardiovascular disease. The respiratory disease segment is predicted to showcase significant growth over the forecast period, mainly owing to the large patient pool diagnosed with respiratory diseases along with the increasing exposure to integral factors of risk like pollution and the rising number of epidemic outbreaks of infections to the respiratory organs.

 

Key market players included in the global clinical microbiology industry are Biomerieux, Danaher Corp., Becton, Dickinson and Co., Abbott, Roche Diagnostics, Bruker, Hologic, Bio-Rad, Qiagen, Thermo Fisher Scientific, Agilent, Merck KGaA, Shimadzu, 3M, Neogen.

 

Global Clinical Microbiology Market Segmentation:

By Application

  • Pharmaceutical Applications
  • Food Testing Applications
  • Clinical Applications
  • Energy Applications
  • Chemical & Material Manufacturing Applications
  • Environmental Applications

 

By Product

  • Instruments
    • Laboratory Instruments
      • Incubators
      • Gram Stainers
      • Bacterial Colony Counters
      • Autoclave Sterilizers
      • Microbial Air Samplers
      • Anaerobic Culture Systems
      • Petri Dish Fillers
      • Blood Culture Systems
      • Microbial Culture Systems
      • Other Laboratory Instruments
    • Microbiology Analyzers
      • Molecular Diagnostic Instruments
      • Microscopes
      • Mass Spectrometers
  • Reagents
    • Pathogen-Specific Kits
    • General Reagents

 

By Indication

  • Respiratory Diseases
  • Bloodstream Infections
  • Gastrointestinal Diseases
  • Sexually Transmitted Diseases
  • Urinary Tract Infections
  • Periodontal Diseases
  • Other Indications

 

By End User

  • Hospitals & Diagnostic Centres
  • Custom Lab Service Providers
  • Academic & Research Institutes

 

By Region 

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

 

FutureWise Key Takeaways:

• Growth prospects

• SWOT analysis 

• Key trends 

• Key data-points affecting market growth 

 

Objectives of the Study:

  • To provide with an exhaustive analysis on the global clinical microbiology market by application, by product, by indication, by end user and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market 
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific and the rest of the world
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financials and core competencies

 

Get unlimited analyst support and customise this study further to your requirements, contact sales@futurewiseresearch.com